Stephen Graham, MD
Pain Medicine · Frisco, TXNPI 1841228640
Payments from drug & device makers
Across 38 payments — averaging $21.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$125
- Amgen$98
- Boston Scientific$98
- Sumitomo Pharma America, Inc.$50
- Pacira Pharmaceuticals Incorporated$48
- UCB, Inc.$47
- plus $367 from 15 others
What the payments were for
- Food & beverage$832100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 6 | $125 |
| Amgen | 5 | $98 |
| Boston Scientific | 1 | $98 |
| Sumitomo Pharma America, Inc. | 2 | $50 |
| Pacira Pharmaceuticals Incorporated | 2 | $48 |
| UCB, Inc. | 3 | $47 |
| SK Life Science, Inc. | 2 | $40 |
| Abbott | 2 | $39 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| EMD Serono, Inc. | 2 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| AstraZeneca | 1 | $24 |
| Aucta Pharmaceuticals, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $24 |
| Merz Pharmaceuticals, LLC | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $17 |
| CSL Behring | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Neurelis, Inc. | 1 | $13 |
| Axsome Therapeutics, Inc. | 1 | $13 |
How this compares
$832 in reported general payments places this provider in the 25th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methadone Hcl | 11 | $886 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $714 |
| Tizanidine Hcl | 29 | $511 |
| Gabapentin | 38 | $397 |
| Morphine Sulfate ErMorphine Sulfate | 11 | $281 |
| Nortriptyline Hcl | 12 | $123 |
| Topiramate | 12 | $80 |
| Pregabalin | 12 | $66 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Frisco
- David KeelenFrisco$35K
- Shamim BadiyanFrisco$24K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Muhammad ZulqarnainDallas$556K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
- David LeimanHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.